Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines

被引：0
|
作者：
Khochikar, Makarand V. [1 ]
机构：
[1] Siddhi Vinayak Ganapati Canc Hosp, Dept Urooncol, Miraj, India
来源：
INDIAN JOURNAL OF UROLOGY | 2007年 / 23卷 / 01期
关键词：
Cancer-specific chemotherapy; castrate levels; hormone-resistant prostate cancer; psycho-oncology; secondary hormonal therapy; supportive care;
D O I：
10.4103/0970-1591.30271
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Treatment of hormone-resistant prostate cancer can be a challenging situation. The first important step in treating this condition is to assess if one has achieved the castrate level or not. If the castrate levels are not achieved, attempt should be made to achieve so. If the castrate level is achieved, then androgen withdrawals may be of help. Supportive care, care of the clinical problems forms an integral part of the treatment. Cancer-specific chemotherapy is certainly an option in progressive disease.
引用
收藏
页码：67 / 69
页数：3
相关论文
共 50 条
  • [21] Value of mitoxantrone in hormone-resistant metastatic prostate cancer - Commentary
    Coulange, C
    PROGRES EN UROLOGIE, 2002, 12 (01): : 41 - 41
  • [22] Phase II trial of vinorelbine and estramustine in the treatment of metastatic hormone-resistant prostate cancer
    Borrega, P
    Velasco, A
    Bolaños, M
    Pérez, MD
    Mel, JR
    Reina, JJ
    Rodríguez-Jaraiz, MA
    Chaves, M
    González-Barón, M
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (01) : 32 - 35
  • [23] Role of mitoxantrone in the management of hormone-resistant metastatic prostate cancer
    Culine, S
    PROGRES EN UROLOGIE, 2002, 12 (01): : 31 - 35
  • [24] Gene amplifications associated with the development of hormone-resistant prostate cancer
    Edwards, J
    Krishna, S
    Witton, CJ
    Bartlett, JMS
    CLINICAL CANCER RESEARCH, 2003, 9 (14) : 5271 - 5281
  • [25] Rapid progression of advanced "hormone-resistant" prostate cancer during palliative treatment with progestins for cancer cachexia
    Tassinari, D
    Fochessati, F
    Panzini, I
    Poggi, B
    Sartori, S
    Ravaioli, A
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 25 (05) : 481 - 484
  • [26] UK STUDIES ON SURAMIN THERAPY IN HORMONE-RESISTANT PROSTATE-CANCER
    KEHINDE, EO
    TERRY, TR
    MISTRY, N
    HORSBURGH, T
    SANDHU, DP
    BELL, PRF
    CANCER SURVEYS, 1995, 23 : 217 - 229
  • [27] TREATMENT OF STAGE D HORMONE-RESISTANT CARCINOMA OF THE PROSTATE WITH ESTRAMUSTINE PHOSPHATE
    BENSON, RC
    WEAR, JB
    GILL, GM
    JOURNAL OF UROLOGY, 1979, 121 (04): : 452 - 454
  • [28] SURAMIN TREATMENT OF HORMONE-RESISTANT PROSTATE-CANCER - EFFECTIVE THERAPY WITH 2 UNEXPECTED TOXICITIES
    KREISLE, W
    MIRANDA, E
    GAREWAL, H
    AHMANN, F
    CLINICAL RESEARCH, 1991, 39 (01): : A105 - A105
  • [29] Inelcalcitol targets vitamin D receptors in hormone-resistant prostate cancer
    不详
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (01) : 6 - 6
  • [30] What is the pathophysiology of a hormone-resistant prostate tumour?
    Tombal, Bertrand
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S179 - S188
12345